CCIA
RCKT icon

Campbell & Co Investment Adviser’s Rocket Pharmaceuticals RCKT Stock Holding History

Campbell & Co Investment Adviser’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-90,084
Closed -$601K – 1411
2025
Q1 		$601K Buy
90,084
+30,115
+50% +$298K 0.05% 605
2024
Q4 		$754K Buy
59,969
+33,718
+128% +$508K 0.06% 508
2024
Q3 		$485K Buy
26,251
+8,259
+46% +$169K 0.04% 733
2024
Q2 		$387K Buy
+17,992
New +$413K 0.03% 741
2022
Q2 		– Sell
-14,949
Closed -$237K – 873
2022
Q1 		$237K Buy
+14,949
New +$258K 0.06% 569
2021
Q4 		– Sell
-11,100
Closed -$332K – 778
2021
Q3 		$332K Buy
+11,100
New +$404K 0.11% 346

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return